0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover210.32%IV-87.97%PremiumAug 16, 2024Expiry Date8.19Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8158Delta0.0542Gamma1.09Leverage Ratio-0.0259Theta-0.0078Rho-0.89Eff Leverage0.0064Vega
American Vanguard Stock Discussion
Salim Ramji, the former head of $Blackrock(BLK.US)$ 's iShares and Index Investments, will take over as CEO of the asset management giant $American Vanguard(AVD.US)$ in July. This marks the first time in Vanguard's 50-year history that the company has appointed a CEO from outside the company. 🚀
Moreover, the new CEO, Ramji, is known for being "crypto-friendly." In contrast, Vanguard's previous stance was to stay far aw...
$OptiNose(OPTN.US)$ all analysts target price 3
$Arcutis Biotherapeutics(ARQT.US)$ avg target price 9.6 (low 4, high 20)
Some of its chart show something good is going to happen, hope no more prank coming from these.
Vanguard and Blackrock also added position on September... ARQT has Vanguard only added position...
still have to wait FDA result though, nothing can be assured. the FDA tracker dot com only provide the...
1. The 2022 strategic review by noting that we have also strengthened our balance sheet while returning significant value to our investors through increased dividends and share repurchases.
2. Our activities to invest to grow our business is a constant focus for the company. We focus on the development and full commercialization of our SIMPAS Ultimus technologies, for example, with the intro...
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US)$ +14.3% (earnings report)
• $Plug Power(PLUG.US)$ +9.24% (t...
I feel like working on this on my own.
No comment yet